Haya Therapeutics logo

Haya Therapeutics

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

3

Funding Rounds

$1.1b

Money raised

Overview

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Funding

Funding series

Funding Series Analysis

The company Haya Therapeutics has raised a total of $1.08b in funding over 3 rounds.

Key Insights:

  • HAYA Therapeutics Series A Round, May 2025: $65m
  • Haya Therapeutics Venture Round, September 2024: $1b
  • Haya Therapeutics , May 2021: $18m
Haya Therapeutics logo
HAYA Therapeutics Series A Round, May 2025 $65m
Haya Therapeutics logo
Haya Therapeutics Venture Round, September 2024 $1b
Haya Therapeutics logo
Haya Therapeutics , May 2021 $18m

Industries

Haya Therapeutics is active in the following industries: